In a study led by City of Hope, the RefleXion® X1 met both the repeatability criteria (87%-91%) and the reproducibility criteria (98%) for the CT radiomic features produced. This is an essential first step in developing imaging biomarkers to one day predict clinical outcomes and response rates for patients with solid tumors. It also demonstrates the utility of the X1 as a quantitative imaging platform. Click below to view the published study.
